UT Health Science Center San Antonio spin-out company Rapamycin Holdings licenses drug’s intellectual property
December 7, 2012
…the promise suggested for rapamycin-related drugs. With insight into the drug’s apparent mechanisms of action, Z. Dave Sharp, Ph.D., professor of molecular medicine at the Health Science Center, proposed the…